NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced the release of a biopharma royalty market study conducted by Deloitte. The report, titled "Role of ...
Diversified Royalty delivered a decent quarter and hiked its dividend by 10%. The company's latest acquisition supports the move. We break down the numbers and tell you where we stand. We still don't ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback